REAL-WORLD STUDY ON THE PATTERNS AND COST OF TREATMENT FAILURE IN PATIENTS WITH PSORIATIC ARTHRITIS USING US CLAIMS DATA

被引：1
|
作者：
Price, K. [1 ]
Alemao, E. [1 ]
Burns, L. [1 ]
Guo, Z. [1 ]
Anupindi, V. [2 ]
Goday, S. [3 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Mu Sigma, Princeton, NJ USA
[3] Mu Sigma, Bangalore, Karnataka, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1476
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0499
引用
收藏
页码：677 / 677
页数：1
相关论文
共 50 条
  • [41] Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
    Littlejohn, Geoffrey
    Leadbetter, Joanna
    Butcher, Belinda E.
    Feletar, Marie
    O'Sullivan, Catherine
    Smith, Tegan
    Witcombe, David
    Ng, Ho Yin
    Youssef, Peter
    CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1579 - 1589
  • [42] Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
    Geoffrey Littlejohn
    Joanna Leadbetter
    Belinda E. Butcher
    Marie Feletar
    Catherine O’Sullivan
    Tegan Smith
    David Witcombe
    Ho Yin Ng
    Peter Youssef
    Clinical Rheumatology, 2024, 43 : 1579 - 1589
  • [43] Real World Treatment Patterns of US Patients With Worsening Chronic Heart Failure: Evidence From Linked PINNACLE Registry and Claims Data
    Butler, Javed
    Fonseca, Eileen
    Yang, Mei
    Manzi, Massimiliano A.
    Patel, Mahesh J.
    Hess, Gregory P.
    Rhodes, Thomas
    Givertz, Michael M.
    CIRCULATION, 2017, 136
  • [44] Real-world trends in biologic, oral systemic, and phototherapy in US patients with psoriasis or psoriatic arthritis
    Singh, Partik
    Silverberg, Jonathan I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 256 - 257
  • [45] USE OF IXEKIZUMAB FOR PSORIATIC ARTHRITIS PATIENTS IN REAL-WORLD CONDITIONS
    Joven, B.
    Hernandez Sanchez, R.
    Perez Pampin, E.
    Aragon Diez, A.
    Almodovar, R.
    Martinez-Ferrer, A.
    Belzunegui, J.
    Rubio, E.
    Diaz Cerezo, S.
    Moyano, S.
    Trancho, L.
    Gomez Barrera, M.
    Munoz, A.
    Nunez, M.
    VALUE IN HEALTH, 2022, 25 (12) : S21 - S21
  • [46] EARLY REAL-WORLD EXPERIENCE OF TOFACITINIB FOR PSORIATIC ARTHRITIS: DATA FROM A UNITED STATES HEALTHCARE CLAIMS DATABASE
    Mease, P. J.
    Young, P.
    Gruben, D. C.
    Fallon, L.
    Germino, R.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1286 - 1287
  • [47] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Mease, Philip
    Young, Pamela
    Gruben, David
    Fallon, Lara
    Germino, Rebecca
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [48] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Mease, Philip J.
    Young, Pamela
    Gruben, David
    Fallon, Lara
    Germino, Rebecca
    Kavanaugh, Arthur
    ADVANCES IN THERAPY, 2022, 39 (06) : 2932 - 2945
  • [49] Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
    Philip J. Mease
    Pamela Young
    David Gruben
    Lara Fallon
    Rebecca Germino
    Arthur Kavanaugh
    Advances in Therapy, 2022, 39 : 2932 - 2945
  • [50] Real-world persistence and treatment patterns in psoriatic arthritis patients treated with anti-1117 therapy: the PERFIL-17 study
    Joven Ibanez, B.
    Fito Manteca, C.
    Rubio, E.
    Raya, E.
    Perez-Linaza, A.
    Hernandeze, R.
    Manrique-Arija, S.
    Nunez, M.
    Diaz, S.
    Trancho, L.
    Garcia de Vicuna, R.
    Adler, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 78 - 78
12345